- S&P 5007,561.67−0.40%
- Nasdaq 10027,943.74−1.22%
- NVDA$162.85−2.01%
- AAPL$356.27+0.39%
- MSFT$523.88+0.17%
- GOOGL$295.77−0.98%
- AMZN$266.66−0.29%
- META$641.69+2.90%
- TSLA$390.22−1.82%
- AVGO$347.01−4.76%
- AMD$534.06−8.75%
- MU$778.31−2.52%
Stock news
317 stories
Market narrative auditsFlux Power Holdings, Inc. (NASDAQ: FLUX) Faces a 50-Day Equity DeadlineIts lender still calls the battery-pack maker in default and now requires at least $4 million of net equity proceeds within 50 days. FLUX · OptimistFi Research Desk · 
Market narrative auditsHecla Mining Company (NYSE: HL) Did Not Add $500 Million of DebtThe new revolving facility more than doubles committed borrowing capacity, but capacity is not the same as an outstanding loan. HL · OptimistFi Research Desk · 
Market narrative auditsWilliams-Sonoma, Inc. (NYSE: WSM) Sales Rise as Clean Margin SlipsComparable sales grew 6.2%, but adjusted operating margin fell 60 basis points as tariff costs pressured merchandise margins. WSM · OptimistFi Research Desk · 
Market narrative auditsAsif Suria Spots Repeat Buying at Celsius Holdings, Inc. (NASDAQ: CELH)Suria says long-tenured independent directors can offer a stronger signal. New filings make that lens testable at Celsius Holdings, Inc. (NASDAQ: CELH). CELH · OptimistFi Research Desk · 
Investor guidesWhy Is Novo Nordisk A/S (NYSE: NVO) Stock Down 15% This Year?Lower U.S. prices and tougher GLP-1 competition outweighed stronger pill demand and two guidance upgrades. NVO · OptimistFi Research Desk · 
Market narrative auditsDillard’s, Inc. (NYSE: DDS) Is Leaving the NYSE for TXSETrading is expected to shift on Oct. 5 with no action needed from shareholders. The move changes the venue, not Dillard’s operating case. DDS · OptimistFi Research Desk · 
Market narrative auditsBiotech2k Tests Cogent Biosciences, Inc. (NASDAQ: COGT) Safety FearBiotech2k separates laboratory results from a broader liver-safety signal. Cogent's new FDA milestone does not settle the eventual label. COGT · OptimistFi Research Desk · 
Investor guidesWhy Is lululemon athletica inc. (NASDAQ: LULU) Stock Down 52% This Year?Americas sales weakened, annual guidance fell by $1 billion, and a tariff refund flattered reported margins. LULU · OptimistFi Research Desk · 
Investor guidesAlamar Biosciences, Inc. (NASDAQ: ALMR) Stock Is Up 13%: The Investment CaseThe proteomics company is growing quickly, but its valuation already assumes strong execution against larger rivals. ALMR · OptimistFi Research Desk · 
Market narrative auditsBerkshire Hathaway Inc. (NYSE: BRK.B) Keeps Greg Abel in ChargeHoward Buffett will guard the culture, while Greg Abel runs a company holding $359.2 billion in cash and Treasury bills at June 30. BRK-B · OptimistFi Research Desk · 
Market narrative auditsNauticus Robotics, Inc. (NASDAQ: KITT) Debt Deal Buys More TimeA January 2028 maturity helps, but first-half operating cash use was more than 13 times revenue and financing risk remains high. KITT · OptimistFi Research Desk · 
Market narrative auditsLisata Therapeutics, Inc. (NASDAQ: LSTA) Holders Keep 2.39%The $225 million financing could extend runway into 2028, but the Marea deal and new money leave pre-transaction owners with 2.39% of the combined company. LSTA · OptimistFi Research Desk ·
HL · OptimistFi Research Desk · 
WSM · OptimistFi Research Desk · 
CELH · OptimistFi Research Desk · 
NVO · OptimistFi Research Desk · 
DDS · OptimistFi Research Desk · 
COGT · OptimistFi Research Desk · 
LULU · OptimistFi Research Desk · 
KITT · OptimistFi Research Desk ·